Prof. M.D.
Melih Cem Börüban
Medical Oncology
Education
- University:University of Hacettepe Faculty of Medicine Ankara/Turkey 1987-1994
- Internal Medicine Residency:Yıldırım Beyazıt Education and Research Hospital Ankara / Turkey 1995-1999
- Medical Oncology Recidency: University Ankara Faculty of Medicine Department of Medical Oncology Ankara /Turkey 2000-2002
- Medical Oncology Consultant:Etlik Ankara Education Hospital Medical Oncology Deparment 2002-2004
- Assistant Professor:University Of Selcuk Faculty of Medicine Medical Oncology Department 2004-2008
- Observer:University of Texas MD Anderson Cancer Center Jynecologic Oncology Department Texas/US 2006
- Associate Professor and Head of Department:Necmettin Erbakan University Faculty of Medicine 2008-2013
- Professor: (Head of Deparment)Necmettin Erbakan University Faculty of Medicine 2013-2016
- Medical Oncology Consultant:Yalova Hospital Medical Oncology Clinic 2017-2022
Work Experience / Post-Specialist Training
- Medical Oncology Specialist – Etlik Specialized Hospital
- Assistant Professor – Selcuk University
- Observer – University of Texas MD Anderson Cancer Center
- Professor and Head of Department – Necmettin Erbakan University
Medical Interests
- Lung
- Gastrointestinal System
- Genital and Urinary System
- Central Nervous System
- Other Malignancies
A1) Geredeli C, Boruban MC, Poyraz N, Artac M, Aribas A, Koral L. Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma. Case Rep Cardiol. 2015;2015:958756. |
A2) Geredeli C, Artac M, Yildirim S, Inal A, Dede I, Guler T, Boruban MC, Koral L, Karaagac M, Zamani AG, Altinok T, Aribas O, Bozcuk H, Demirkazik A. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. Tumour Biol. 2015 Jun;36(6):4279-85. |
A3) Mehmet K, Sener C, Uyeturk U, Seker M, Tastekin D, Tonyali O, Balakan O, Yazici OK, Urakci Z, Isikdogan A, Ozdemir N, Inal A, Kaplan MA, Suner A, Dal S, Uncu D, Gumus M, Boruban MC, Oksuzoglu B, Ayyildiz O, Benekli M. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology. Contemp Oncol (Pozn). 2014;18(4):273-8. |
A4) Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A. Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).Int Surg. 2014 Jan-Feb;99(1):2-7. |
A5) Cetin B, Benekli M, Turker I, Koral L, Ulas A, Dane F, Oksuzoglu B, Kaplan MA, Koca D, Boruban C, Yilmaz B, Sevinc A, Berk V, Uncu D, Harputluoglu H, Coskun U, Buyukberber S. Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO). J Chemother. 2014 Oct;26(5):300-5. |
A6) Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. Breast Cancer. 2014 Nov;21(6):677-83.
|
A7) Artac M, Koral L, Toy H, Guler T, Boruban MC, Altundag K. Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases. J Oncol Pharm Pract. 2014 Apr;20(2):141-5. |
A8) Cetin B, Benekli M, Dane F, Boruban C, Gumus M, Oksuzoglu B, Kaplan MA, Tufan G, Sevinc A, Coskun U, Buyukberber S. Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience. Breast Care (Basel). 2013 Mar;8(1):67-70
|
A9) Artac M, Bozcuk H, Kiyici A, Eren OO, Boruban MC, Ozdogan M. Breast Cancer. 2013 Apr;20(2):174-80.
|
A10) Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Suner A, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A .Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology. Ann Ital Chir. 2013 Mar-Apr;84(2):143-8.
|
A11) Urun Y, Kankaya D, Koral L, Yalcin B, Karabork A, Ceyhan K, Boruban MC, Utkan G, Demirkazik A. Tumori. 2013 Mar-Apr;99(2):e65-9.
|
A12) Alihanoğlu YI, Kaya Z, Arı H, Karaarslan S, Yıldız BS, Karanfil M, Yazıcı M, Börüban MC, Ozdemir K, Ulgen MS. Turk Kardiyol Dern Ars. 2012 Oct;40(7):597-605.
|
A13) Cetin B, Benekli M, Oksuzoglu B, Koral L, Ulas A, Dane F, Turker I, Kaplan MA, Koca D, Boruban C, Yilmaz B, Sevinc A, Berk V, Isıkdogan A, Uncu D, Harputluoglu H, Coskun U, Buyukberber S. Onkologie. 2012;35(12):740-5
|
A14) Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Oncology. 2012;83(3):141-50
|
A-15) Boruban C, Gulyer H, Altundag K, Artac M, Güler T, Cengiz M. Evaluating The Clinicopathologic Characteristics and Survival Outcome of Breast Cancer Patients with Isolated Brain Metastases after Adjuvant Treatment or at Initial Diagnosis Eur J Gen Med 2012;9(4):265-269
|
A1) A16) ) Buyukdogan M, Boruban C, Artac M, Demirel S ‘Frequency of cytocrom P450 2C9 and 2C19 genetic polymorphism in patients with colorectal carcinoma’ Int.Journal of Hematology and Oncology 2009 september; 19(4)134
|
A17) Eren OO, Artac M, Boruban MC, Yavas O, Arslan U, Basaranoglu M.’Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.’Med Oncol. 2009 December;26(4):386-92 |
A18) Boruban C, Onur H The Role of Thrombomodulin in the Increased Tendency of Hypercoagulability in Patients Treated with Cisplatin Based Chemotherapy Int.Journal of Hematology and Oncology.2008;18(2)85-92 |
A19) Boruban C, Jaıshuen A, Sırısabya N, Lı Y, Zheng H, Deavers M, Kavanagh J ‘Ovarian endometriosis associated with carcinoma and sarcoma’ Eur. J of Gynecological Oncol.2008 29(4);393-96 |
A20) Yavas O, Yazici M, Eren O, Boruban C, Artac M, Genc M. The acute effect of tropisetron on ECG parameters in cancer patients. Support Care Cancer. 2008 Sep; 16(9):1011-1015 |
A21)Boruban C, J “From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. ”, Eur J Cancer Prev. 2008 Apr;17(2):133- |
A22) Kilic GS, Boruban C, Ramos CB, Konoplev SN. “Granulocytic sarcoma involving the uterus and right fallopian tube with negative endometrial biobsy ” Eur J Gynaecol Oncol. 2007;28(4):270-2. |
A23) Boruban C, Sencan O, Akmansu M, Tunç Atik E, Ozbek S. “ Metastatic gastrointestinal stromal tumor treated with concomitant radiotherapy and imatinib mesylate with long-term duration of response. ” Anticancer Drugs. 2007 Sep;18(8):969-72. |
A24) Sencan O, Buyukcelik A, Yalcın B, Boruban C, Akbulut H, Demirkazık A, Senler FC, Onur H, Iclı F “The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma” Eur J Cancer Care (Engl). 2008 Jan;17(1):26-32. |
A25) Boruban C, Yasar U,. Babaoglu M, Sencan O Bozkurt A. “Tamoxifen İnhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients”, Journal of Chemotherapy , 18(4),421-424(2006). (B) |
A26) Güneş A, Coşkun U, Börüban C, Günel N, Sencan O, Bozkurt A, Rane A, Hassan M, Zengil H, Yaşar U. “Inhibitory effects of 5-fluorouracil on CYP2C9 activity in cancer patients. ” Basic &Clin Pharmacol&Toxicol ,98 ,197-200(2006) |
A27) Boruban C, “Synchronous presentation of nasopharyngeal and renal cell carcinomas. ” International Braz J Urol, 32(3),310-312(2006). |
A28) Yavas O, Boruban C, Eren O, Genc M.“Acute Reversible Life-Threatening Encephalopathy Following Conventional Doses Of Paclitaxel Infusion.” The Internet Journal of Oncology, 3, number 2(2006). |
A29) “Recent findings for anti-metastatic potential of heparin. ” Clin Appl Thromb Hemost. 2006 ,12(3),376-377(2006).(B) |
A30) “Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients. ” Medical Hypotheses, 66(1), 211-212(2006). © |
A31) İçli F, Akbulut H, Uner A, Yalcın B, Baltalı E, Altınbaş M, Coskun S, Erkisi M, Demirkazik A, Senler FC, Sencan O, Buyukcelik A, Boruban C, Onur H, Zengin N, Sak SD. “Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines. ” a randomised phase III trial of Turkish OncologyGroup. Br J Cancer,92,639-44(2005).(A) |
A32) Boruban C, Yavas O, “Imatinib may be useful in the management of patients with glioblastoma. ” Medical Hypotheses ,65(6),1205-1206(2005). © |
A33) “Cross-talk between cyclooxygenase-2 and epidermal growth factor receptor in non-small cell lung cancer. ” Lung Cancer, 49(3),429(2005)(B) |
A34) “Hormone receptor status of primary tumor as a prognostic factor in patients with liver metastases from breast cancer treated with transcatheter arterial chemoembolization” W J Gasteroenterol2005 28;11(44):7057 |
A35) “Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view? ” Med Hypotheses,65,194(2005). |
A36) “ The role of insulin-like growth factor-1 receptor in the development of herceptin resistance. ” Molecular Cancer Therapeutics Mol Cancer Ther, 4(7),1136(2005)(B) |
A37) “Are all prognostic factors changing with time in breast cancer? – New proposal for classification of prognostic factors as time-dependent and time-independent. ” Medical Hypotheses, 65(2),413-414(2005). |
A38) “Activation patterns of epidermal growth factor receptor signaling in glioblastoma multiforme. ” Int J Radiat Oncol Biol Phys,62(4),1253(2005)(?) |
A39) “Acidosis might make breast cancer cells more susceptible to metastasize by shifting CXCL12 monomer-dimer equilibrium to monomeric state. ” Medical Hypotheses, 65(3),626-627(2005). |
A40) “Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. ” Medical Hypotheses, 65(4),819-820(2005). |
A41) “ Imatinib mesylate lacks activity in small cell lung carcinoma expressing C-kit protein: a Phase II clinical trial. ” Cancer, 104(9),2033-2034(2005) |
A42) Ozdemir F, Esen N, Ovali E, Tekelioglu Y, Yilmaz M, Aydin F, Kavgaci H , Boruban C. “ Effects of dexamethasone, all-trans retinoic acid, vitamin D(3) and interferon-alpha on FO myeloma cells. ” Chemotherapy,50,190-193(2004). |
A43) Kavgaci H, Boruban MC, Alver G, Sak SD, Demirkazik A,Icli F, Isikdogan A. “Respiratory distress due to endotracheal aspergilloma in an immunocompromised lymphoma patient” case report. J Chemother, 14(1), 92-94(2002).
|
B.Posters in International meetings |
1- Caglayan Geredeli, Mehmet Artac, Selman Yildirim, Isa Dede, Ali Inal, Tunc Guler, Melih Cem Boruban, Ayse Gul Zamani, Hakan Bozcuk, Ahmet Demirkazik; Necmettin Erbakan University Meram Medical Faculty, Department of Medical Oncology, Konya, Turkey; Necmettin Erbakan University Meram Medical Faculty, Department of Genetics, Konya, Turkey; Ankara University Medical Faculty Department of Medical Oncology, Ankara, Turkey; Dicle University, Diyarbakir, Turkey; Akdeniz University Medical Faculty Department of Medical Oncology, Antalya, Turkey; Ankara University School of Medicine, Ankara, Turkey The prognostic role of XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms (SNPs) in resected non-small cell lung cancer (NSCLC). ASCO annual meeting 2013
|
2- Ülkü Yalçintas Arslan, Caglayan Geredeli, Nuriye Özdemir, Aydin Ciltas, Ozlem Sonmez, Mehmet Kucukoner, Halit Karaca, Ayse Gok Durnali, Melih Cem Boruban, Nurullah Zengin, Suleyman Buyukberber, Ali Suner, Mesut Seker, Necati Alkis, Omur Berna Oksuzoglu; Ankara Oncology Training and Research Hospital, Ankara, Turkey; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University Cancer Center, Konya, Turkey; Ankara Numune Hospital, Ankara, Turkey; Gazi University, Department of Medical Oncology, Ankara, Turkey; Dr. Abdurrahman Yurtaslan Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Department of Medical Oncology,Dicle University, Diyarbakir, Turkey; Medical Oncology Department of Erciyes University, Kayseri, Turkey; Deparment of Medical Oncology, Faculty of Medicine, Selcuk University Cancer Center, Konya, Turkey; Numune Education and Research Hospital, Ankara, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Medical Faculty, Medical Oncology Department, Gaziantep, Turkey; Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey; Ankara Oncology Research and Education Hospital, Ankara, Turkey A retrospective evaluation of locally advanced thymoma and thymic carcinoma: Factors influencing the prognosis after local treatment modalities. ASCO annual meeting 2013
3- Nurgul Yasar, Olcun Umit Unal, Caglayan Geredeli, Ali Inal, Veli Berk, Ebru Sari, Ayse Durnali, Ali Suner, Nuriye Ozdemir, Burcin Budakoglu, Umut Demirci, Ozge Gumussoy, Dogan Uncu, Cem Melih Boruban, Ilhan Oztop, Metin Ozkan, Mahmut Gumus, Tamer Elkiran, Anatolian Medical Oncology; Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey; Faculty of Medicine, Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkey; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University Cancer Center, Konya, Turkey; Dicle University, Diyarbakir, Turkey; Faculty of Medicine, Department of Medical Oncology, Erciyes University, Kayseri, Turkey; Süreyyapaþa Chest Diseases Hospital, istanbul, Turkey; Abdurrahman Yurtaslan Oncology Hospital, Ankara, Turkey; Gaziantep University Medical Faculty, Medical Oncology Department, Gaziantep, Turkey; Ankara Numune Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Ankara Oncology Training and Research Hospital, Ankara, Turkey; Department of Medical Oncology, Ankara Ataturk Education and Research Hospital, Ankara, Turkey; 11Gazi University Faculty of Medicine, ankara, Turkey; Ankara Numune Training and Research of Medical Oncology, Ankara, Turkey; Selçuk University Meram Faculty of Medicine, Konya, Tunisia; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology, Dr. Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey Efficacy and safety results of pemetrexed administration in non-small cell lung cancers, a multicenter study of the Association of Anatolian Medical Oncology. ASCO annual meeting 2013
|
4- Ugur Coskun, Mahmut Gumus, Dogan Uncu, Metin Ozkan, Irfan Cicin, Kadri Altundag, Tamer Elkiran, Murat Kocer, Aziz Karaoglu, Nilufer Avci, Feyyaz Ozdemir, Erdem Cubukcu, Melih Cem Boruban, Alper Sevinc, Berna Oksuzoglu, Hande Turna, Bulent Yalcin, Esra Dumanli, Fatih Ozdener, Mustafa Benekli, Turkish OncoRegistry Study Group; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Dr. Lutfi Kirdar Kartal Education and Research Hospital, Department of Medical Oncology, Istanbul, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey; Suleyman Demirel University, Isparta, Turkey; Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkey; Balikesir State Hospital, Balikesir, Turkey; Karadeniz Technical University School of Medicine, Trabzon, Turkey; Department of Medical Oncology, Ali Osman Sonmez Oncology Hospital, Bursa, Turkey; Necmettin Erbakan University Meram Medical Faculty Department of Medical Oncology, Konya, Turkey; Department of Medical Oncology, Gaziantep University, Gaziantep, Turkey; Ankara Oncology Research and Training Hospital Department of Medical Oncology, Ankara, Turkey; Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey; Department of Oncology, Yildirim Beyazit University School of Medicine, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey Turkish Breast Cancer Registry: A multicenter epidemiologic study. ASCO annual meeting 2014
|
5- Aydin Ciltas, Mustafa Karaca, Dogan Uncu, Metin Ozkan, Mehmet Aliustaoglu, Salim Basol Tekin, Irfan Cicin, Murat Kocer, Faysal Dane, Berna Oksuzoglu, Abdurrahman Isikdogan, Feyyaz Ozdemir, Emin Tamer Elkiran, Aziz Karaoglu, Bulent Yalcin, Alper Sevinc, Mukremin Uysal, CEM Boruban, Mustafa Benekli, Suleyman Buyukberber, Nilufer Avci, Banu Ozturk, Arife Ulas, Hande Turna, Ruchan Uslu, Esra Dumanli, Huseyin Abali, Oguz Kara, Mahmut Gumus,; Gazi University Medical Faculty, Ankara, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Haydarpasa Numune Hosp, Kad Istanbul, Turkey; Ataturk University Faculty of Medicine, Erzurum, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Suleyman Demirel University, Isparta, Turkey; Marmara University, Medical Oncology, Istanbul, Turkey; Ankara Oncology Research and Training Hospital Department of Medical Oncology, Ankara, Turkey; Dicle University Medical School, Diyarbakir, Turkey; Karadeniz Technical University School of Medicine, Trabzon, Turkey; Inonu University Medical Faculty, Malatya, Turkey; Dokuz Eylul University, Balcova, Turkey; Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey; Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey; Konya University Medical Faculty, Istanbul, Turkey; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry. ASCO annual meeting 2015
|
6- Ramazan Yildiz, Suleyman Buyukberber, Dogan Koca, Lokman Koral, Aydin Ciltas, Olcun Umit Unal, Mahmut Gumus, Nuriye Ozdemir, Faysal Dane, Veli Berk, Mehmet Ali Kaplan, Tamer Elkiran, Melih Cem Boruban, Ugur Coskun, Dincer Aydin, Dogan Uncu, Metin Ozkan, Abdurrahman Isikdogan, Mustafa Benekli, Anatolian Society of Medical Oncology (ASMO); Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Gazi University Hospital, Ankara, Turkey; Faculty of Medicine, Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkey; Deparment of Medical Oncology, Faculty of Medicine, Selcuk University Cancer Center, Konya, Turkey; Gazi University, Department of Medical Oncology, Ankara, Turkey; Dr. Lutfi Kirdar Kartal Education and Research Hospital, Department of Medical Oncology, Istanbul, Turkey; Ankara Numune Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Marmara University Hospital, Istanbul, Turkey; Faculty of Medicine, Department of Medical Oncology, Erciyes University, Kayseri, Turkey; Dicle University, Department of Medical Oncology, Diyarbakir, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey; Konya University Meram Medical Faculty Department of Medical Oncology, Konya, Turkey; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Ankara Numune Training and Research of Medical Oncology, Ankara, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology,Dicle University, Diyarbakir, Turkey; Faculty of Medicine, Department of Medical Oncology, Gazi University, Ankara, Turkey The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience. ASCO annual meeting 2015
|
7- Mustafa Benekli, Esra Dumanli, Saadettin Kilickap, Dogan Uncu, Mehmet Aliustaoglu, Irfan Cicin, Mahmut Gumus, Metin Ozkan, Murat Kocer, Aziz Karaoglu, Faysal Dane, Abdurrahman Isikdogan, Tamer Elkiran, Bulent Yalcin, Mukremin Uysal, Berna Oksuzoglu, Melih Cem Boruban, Arife Ulas, Huseyin Abali, Suleyman Buyukberber, Salim Basol Tekin, Nilufer Avci, Alper Sevinc, Feyyaz Ozdemir, Ruchan Uslu, Hande Turna, Banu Ozturk, Oguz Kara, Ali Osman Kaya; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Hacettepe University Hospital, Sivas, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Haydarpasa Numune Hosp, Kad Istanbul, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Kartal Research and Training Hospital, Istanbul, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Suleyman Demirel University, Isparta, Turkey; Dokuz Eylul University, Balcova, Turkey; Marmara University Hospital, Istanbul, Turkey; Dicle University Medical School, Diyarbakir, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey; Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey; Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey; Necmettin Erbakan University Meram Medical Faculty Department of Medical Oncology, Konya, Turkey; Ali Osman Sonmez Oncology Hospital, Department of Medical Oncology, Bursa, Turkey; Acibadem Adana Hastanesi, Adana, Turkey; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
Turkish National Colon Cancer Registry. ASCO annual meeting 2015
|
8- Suleyman Buyukberber, Esra Dumanli, Dogan Uncu, Metin Ozkan, Ruchan Uslu, Gamze Gokoz Dogu, Oguz Kara, Huseyin Abali, Hande Turna, Banu Ozturk, Alper Sevinc, Mukremin Uysal, Bulent Yalcin, Faysal Dane, Mehmet Aliustaoglu, Irfan Cicin, Salim Basol Tekin, Mahmut Gumus, Saadettin Kilickap, Mustafa Benekli, Murat Kocer, Berna Oksuzoglu, Abdurrahman Isikdogan, Feyyaz Ozdemir, E. Tamer Elkiran, Aziz Karaoglu, Cem Boruban, Nilufer Avci; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Ege University School of Medicine, Izmir, Turkey; Pamukkale University Medical Faculty, Department of Medical Oncology, Kayseri, Turkey; Cukurova Univeristy Faculty of Medicine, Adana, Turkey; Acibadem Adana Hastanesi, Adana, Turkey; Istanbul University Cerrahpasa Faculty of Medicine, Department of Oncology, Istanbul, Turkey; Department of Medical Oncology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey; Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey; Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey; Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Marmara University Hospital, Istanbul, Turkey; Haydarpasa Numune Hosp, Kad Istanbul, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Ataturk University Faculty of Medicine, Erzurum, Turkey; Kartal Research and Training Hospital, Istanbul, Turkey; Hacettepe University Hospital, Sivas, Turkey; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey Turkish National Gastric Cancer Registry. ASCO annual meeting 2015
|
9- Saadettin Kilickap, Kadri Altundag, Esra Dumanli, Mahmut Gumus, Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Oguz Kara, Gamze Gokoz Dogu, Banu Ozturk, Ali Osman Kaya, Mehmet Aliustaoglu, Dogan Uncu, Feyyaz Ozdemir, Irfan Cicin, Metin Ozkan, Murat Kocer, Hande Turna, Suleyman Buyukberber, Mustafa Benekli, Ugur Coskun, Aziz Karaoglu, Salim Basol Tekin, Faysal Dane, Nilufer Avci, Arife Ulas, Berna Oksuzoglu, Alper Sevinc, Melih Cem Boruban; Hacettepe University Hospital, Sivas, Turkey; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Kartal Research and Training Hospital, Istanbul, Turkey; Ege University School of Medicine, Izmir, Turkey; Department of Medical Oncology, Baskent University Faculty of Medicine, Adana, Turkey; Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Cukurova Univeristy Faculty of Medicine, Adana, Turkey; Pamukkale University Medical Faculty, Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey; Gazi University, Ankara, Turkey; Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Karadeniz Technical University School of Medicine, Trabzon, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Medical Oncology Department, Erciyes University, Kayseri, Turkey; Suleyman Demirel University, Isparta, Turkey; Istanbul University Cerrahpasa Faculty of Medicine, Department of Oncology, Istanbul, Turkey; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey Geographic variations of clinical characteristics in breast cancer: Analysis of
Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry. ASCO annual meeting 2015
|
10- Mustafa Benekli, Kadri Altundag, Esra Dumanli, Abdurrahman Isikdogan, Aziz Karaoglu, Salim Basol Tekin, Berna Oksuzoglu, Murat Kocer, Alper Sevinc, Melih Cem Boruban, Hande Turna, Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Ugur Coskun, Saadettin Kilickap, Gamze Gokoz Dogu, Banu Ozturk, Mahmut Gumus, Suleyman Buyukberber, Dogan Uncu, Oguz Kara, Mehmet Aliustaoglu, Metin Ozkan, Irfan Cicin, E. Tamer Elkiran, Faysal Dane, Nilufer Avci, Arife Ulas, Feyyaz Ozdemir, Ali Osman Kaya; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Dicle University Medical School, Diyarbakir, Turkey; Dokuz Eylul University, Balcova, Turkey; Ataturk University Faculty of Medicine, Erzurum, Turkey; Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey; Suleyman Demirel University, Isparta, Turkey; Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey; Necmettin Erbakan University Meram Medical Faculty Department of Medical Oncology, Konya, Turkey; Istanbul University Cerrahpasa Faculty of Medicine, Department of Oncology, Istanbul, Turkey; Ege University School of Medicine, Izmir, Turkey; Department of Medical Oncology, Baskent University Faculty of Medicine, Adana, Turkey; Yildirim Beyazit University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Gazi University Tip Fakultesi, Ankara, Turkey; Hacettepe University Hospital, Sivas, Turkey; Pamukkale University Medical Faculty, Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey; Kartal Research and Training Hospital, Istanbul, Turkey; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry. ASCO annual meeting 2015
|
11- Kadri Altundag, Esra Dumanli, Mehmet Aliustaoglu, Dogan Uncu, Metin Ozkan, Irfan Cicin, Ugur Coskun, Tamer Elkiran, Murat Kocer, Abdurrahman Isikdogan, Aziz Karaoglu, Salim Basol Tekin, Nilufer Avci, Arife Ulas, Berna Oksuzoglu, Feyyaz Ozdemir, Saadettin Kilickap, Mahmut Gumus, Suleyman Buyukberber, Mustafa Benekli, Faysal Dane, Alper Sevinc, Melih Cem Boruban, Hande Turna, Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Oguz Kara, Gamze Gokoz Dogu, Banu Ozturk, Ali Osman Kaya; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Haydarpasa Numune Hosp, Kad Istanbul, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Medical Oncology Department, Erciyes University, Kayseri, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Gazi University Tip Fakultesi, Ankara, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey; Suleyman Demirel University, Isparta, Turkey; Dicle University Medical School, Diyarbakir, Turkey; Dokuz Eylul University, Balcova, Turkey; Ataturk University Faculty of Medicine, Erzurum, Turkey; Balikesir State Hospital, Balikesir, Turkey; Ali Osman Sonmez Oncology Hospital, Department of Medical Oncology, Bursa, Turkey; Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey; Karadeniz Technical University School of Medicine, Trabzon, Turkey; Hacettepe University Hospital, Sivas, Turkey; Kartal Research and Training Hospital, Istanbul, Turkey; Gazi University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey Turkish National Breast Cancer Registry. ASCO annual meeting 2015
|
12- Ugur Coskun, Kadri Altundag, Mehmet Aliustaoglu, Dogan Uncu, Metin Ozkan, Irfan Cicin, Aydin Ciltas, Tamer Elkiran, Murat Kocer, Abdurrahman Isikdogan, Aziz Karaoglu, Salim Basol Tekin, Nilufer Avci, Arife Ulas, Berna Oksuzoglu, Feyyaz Ozdemir, Esra Dumanli, Alper Sevinc, Saadettin Kilickap, Mustafa Benekli, Ruchan Uslu, Ozgur Ozyilkan, Bulent Yalcin, Melih Cem Boruban, Faysal Dane, Oguz Kara, Gamze Gokoz Dogu, Banu Ozturk, Ali Osman Kaya, Mahmut Gumus, Hande Turna; Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey; Dr. Lütfi Kirdar Kartal Training and Research Hospital, Istanbul, Turkey; Ankara Numune Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Erciyes University Faculty of Medicine Department of Medical Oncology, Kayseri, Turkey; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey; Gazi University Medical Faculty, Ankara, Turkey; Inonu University Faculty of Medicine, Malatya, Turkey; Suleyman Demirel University, Isparta, Turkey; Dicle University Medical School, Diyarbakir, Turkey; Dokuz Eylul University, Balcova, Turkey; Ataturk University Faculty of Medicine, Erzurum, Turkey; Balikesir State Hospital, Balikesir, Turkey; Education and Research Hospital, Bursa, Turkey; Ankara Oncology Research and Training Hospital, Department of Medical Oncology, Ankara, Turkey; Karadeniz Technical University School of Medicine, Trabzon, Turkey; Roche Pharmaceuticals, Istanbul, Turkey; Gaziantep University Faculty of Medicine, Department of Medical Oncology, Gaziantep, Turkey; Hacettepe University Hospital, Sivas, Turkey Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry. ASCO annual meeting 2015
|
12- Mehmet Artac, Dudu Askin, Aysel Kiyici, Onder Orhan Eren, Mufide Oncel, Melih Cem Boruban, Hakan Sat Bozcuk Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients? J Clin Oncol 30, 2012 (suppl; abstr e11008) |
13- Koksal H,Ugras N.S, uysal B, Boruban C. What is themodality of surgical treatmentin well differentiated neuoroendocrine carcinomalocated on the extrahepaticbiliary duct ESSR 46th annual congress Aachen,Germanyp11-7 |
15 M. C. Boruban, N. Govec, M. Artac, L. Koral, C. Geredeli;, ‘‘Is the microcalcification in mammography in patients diagnosed with breast cancer related to the bone metastasis and bad prognostic factors?’’ ASCO 2010 Breast Cancer Symposium Abstract No: 44 |
16- Artaç, M., D. Aşkın, A. Kıyıcı, O. O. Eren, M. Öncel, M. C. Börüban, “The effect of aromatase inhibitors on estradiol, leptin, insulin, and IGF-1levels in breast cancer patients:contributions of obesity related factors,” 8th Mediterranean Conferance on Oncology, “Innovations In Breast Cancer Management” November 28-30, 2010 Antalya -Turkey
|
17- Artaç, M, H. S. Bozcuk, A. Kiyici, O. O. Eren, M. C. Boruban, M. Ozdogan,” Correlation of serum leptin level and waist-to-hip ratio (WHR) with overall survival of patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AIs),” J Clin Oncol (suppl; abstr 1106) 28:15s, 2010.
|
18- M. Ozdogan, A. Kargı, H bozcuk, M.C. Boruban, H.S. Coskun H Mutlı, O.O. Eren, M Uysal, B. Savas Maintainance semi-metronomic oral cyclophospahamide and oral etoposide regimen in extensive stage small cell lung cancer patients after responding firstline treatment European Society of Medical Oncology meeting 2009 Abtract no: 9131
|
19- Odev K,Ozbiner H, Geredeli C,Guler T,Koral L,Tastekin D, Boruban C, Artac M.Cardiac metastases and pulmonary embolism due to malignant melanomaof uterine cervix : Clinical and imaging findings. International Urogenital Radiology joint Meeting of European society of Urogenital Radiology and Society of Uroradiology 2011Abstract no V-11 |
20- Boruban C, Yasar.U, Sencan.O Babaoglu M.O, Bozkurt A. “Effect of Tamoxifen on Cytochrome P540 2C9 enzym activity. ” 40th Annual Meeting of ASCO, New Orleans, Proc. Am. Soc. Clin. Oncol., Vol 23, 160,Abstract # 2133, ASCO, Alexandria VA, USA, 2004. |
|
21- Demirkazık A, Çoban S, Börüban C, Kavgacı H, Akbulut H, Büyükçelik A, “Does Albumin infusion in advanced stage cancer patients with hypoalbuminnemia have a prognostic value.” 38th Annual Meeting of ASCO, Orlando FL, Proc. Am. Soc. Clin. Oncol., Vol 21, 268b, Abstract # 2892, ASCO, Alexandria VA, USA, 2004. |
22- Güneş A, Coşkun U, Börüban C, Günel N, Sencan O, Bozkurt A, Rane A, Hassan M, Zengil H, Yaşar U. “Inhibitory effects of 5-fluorouracil on CYP2C9 activity.” Sixth congress of European association for clinical pharmcology and therapeutics,İstanbul,proc sixth congress of European association for clinical pharmcology and therapeutics,vol 1,142,Abstract # 263 Türkiye 2003 |
23- Altınyazar C, Şencan O, Ekşioğlu F, Börüban C, Aydın N, Kocakavak C. “HI,RES ECG and echocardiographic finding in Behçet desease” 5 th Congress of European Academy of Dermatology and Venerology, Lisbon l, J Eur Acedemy of Dermato Vener.,213, Abstracts # 393 Portugal 1996 |
|
D. Publications in journals out of SCI an SCI expanded |
D1) Alihanoğlu Y.I, Kaya Z, Arı H, Karaarslan S, Yıldız BS, Karanfil M, Börüban M.C, Ozdemir K, Ulgen MS. Assessment of left ventricular systolic and diastolic function with conventional and tissue Doppler echocardiography imaging techniques in patients administered tyrosine kinase inhibitor. Turk Kardiyol Dern Ars. 2012 Nov;40(7):597-605
|
D2) Kutlu R, Çivi S, Börüban M.C, Ruhuşen, Demir A Ayşe ‘’Demir1Kanserli Hastalarda Depresyon ve Yaşam Kalitesini Etkileyen Faktörler’’Selçuk Üniv Tıp Derg,27(3):149-153 (2011)
|
D3) Boruban C, Güler T, geredeli C. The bladder cancer Turkiye Klinikleri J Med Oncol-Special Topics 2011;4(3):18-30
|
D4) Kıyıcı A, Artaç M, Çiçekler H, Eren Ö, Mehmetoğlu İ, Börüban C “Aromataz İnhibitörü Tedavisinin Meme Kanserli Hastalarda Serum Total Siyalik Asit Düzeylerine Etkisi”Selçuk Tıp Derg,26(2):35-37 (2010)
|
D5) Artac M, Eren Ö,Börüban M.C, İnkaya A.Ç. Kemoterapi alan hastalarda hepatit B reaktivasyonu.Viral hep.Dergisi. 2010; 16(2): 69-76 |
D6) Yavaş Ö, Eren Ö, Artaç M, Börüban C, Genç M “A case of superior vena cava syndrome caused by colon cancer treated with bevacizumab combination chemotherapy”Turkish Journal of Cancer ,3(39),115-116, (2009 ) |
D7) Börüban C, Kılıç G “Cushing Sendromu ve adrenal yetmezlik” (Onkolojik aciller sayısı) Türkiye klinikleri J Surg med Sci ,2(33),58-62(2006) |
D8) Kılıç SG, Bildacı TB, Boruban C“ Anormal Uterus kanamasında mikrodalga Endometriyal Ablasyon (MEA) uygulanan hastaların vaka serisi. ” Türk Jinekolojik Onkoloji Dergisi,9(29):39-45(2006) |
D9) Gök M, Börüban C, Toy H, Kanat F, Kurt E,Uzun K “Akciğer kanseri ile nörofibromatozis birlikteliği”Tıp araştırmaları dergisi,4(1),48-51(2006) |
D10) Yalçın B, Zengin N, Aydın F, İlhan M,Işıkdoğan A, Demir G, Aykan F, Çelik İ, Dane F, Üstüner Z, Börüban C, Bozcuk H,Çoşkun Ş, Karaoğlu A, Altunbaş M, Yamaç D, Tek İ,Budakoğlu B, Utkan G, Özdemir F, Aksoy S, Özdemir N, Akbulut H,Büyükçelik A, içli F “The clinical and pathological features of patients with gastric cancer in Turkey. A Turkish Oncology Group study ”Turkish journal of Cancer,36(3),108-115(2006) |
D11) Börüban C, Kocakavak C “Serum fibrinojen düzeyinin koroner arter hastalığının gelişmesi üzerine etkisi.”Dahili Tıp Bilimleri Dergisi ,13(1), 36-41(2006) |
D12) Börüban C, Nurullah Zengin „Lokal ileri ever küçük hücreli dışı akciğer kanserinde tedavi“ Remisyon Güncel Onkoloji Dergisi ,7(3), 110-114(2005) |
D13) Börüban C “Tümör belirleyicilerinin klinikte kullanımı.” Progress İç hastalıkları Dergisi ,4(9),427-429(2003) |
D14) Kocakavak C, Maraş Y, Börüban C, Değirmenci A, Ahipaşaoğlu Y “Sağ koroner arterden çıkan sirkümfleks ve sol ön inen koroner arter anomalisi” Girişimsel Kardioloji Dergisi ,4(2),125-127(2000) |
D15) Kocakavak C, Börüban C, Değirmenci A, Maraş Y, Çeneli Ö, Ahipaşaoğlu Y “Semptomatik koroner arter anevrizmalarının tedavisinde alternatif bir yaklaşım, koroner arter anevrizmasının perkutan translüminal anjioplasti ve politetrafluetilen kaplı stent uygulaması ile oblitere edilmesi olgu sunumu ve literatürün gözden geçirilmesi” Girişimsel Kardioloji Dergisi, (2),86-88(2000) |
D16) Börüban C, Yıldıran L, “Sessiz İskemi” Progress İç hastalıkları Dergisi,1(3),77-80(2000) |
D17) Börüban C, Değirmenci A, Yıldıran L: “Dislipidemiler ve tedavi ilkeleri” Progress İç Hastalıkları Dergisi ,1(2),53-57(2000) |
For Your
Questions
Medistate Kavacık Hospital, which constantly raises the bar in its sector with its professional approach to health and advanced technology, brings two continents together with the quality health services it offers to those living on both the European and Anatolian sides.
444 44 13
Your Customer Agent
We Listen to You
Any comments and suggestions
Let us call you
Leave us your number
E-Newsletter Membership
Keep up to date with the latest news